EQT portfolio companies respond to COVID-19

As the COVID-19 pandemic disrupts societies and impacts everyday lives, businesses are finding new and creative ways to adapt to the current situation. In the light of this ‘new normal’, many of EQT’s portfolio companies have quickly pivoted their operations in response to the outbreak in order t...

EQT supports research and testing initiatives in response to COVID-19

The global outbreak of the COVID-19 pandemic brings unprecedented challenges and everyone is affected one way or another - humans, societies, businesses and the economy as a whole. People across the world are struggling - with the disease, the pressure of potentially losing their jobs, or at the...

EQT enters exclusive negotiations to acquire schülke – a leading provider of infection prevention solutions

EQT enters exclusive negotiations to acquire schülke, a leading provider of hygiene and infection prevention solutions, such as skin and surface disinfection products and wound antisepsis schülke is a pioneer in the infection prevention industry with 130 years of experience, protecting lives...

Tackling remote ways of working

The COVID-19 pandemic is locking down large parts of the world and countries are taking unprecedented actions to prevent and delay the spreading of the Coronavirus. Given this new and unforeseeable situation, many companies urge their employees to work from home as a means of social distancing. T...

EQT on the COVID-19 pandemic

The letter below has been sent to investors in EQT funds from Christian Sinding, CEO and Managing Partner, and Jussi Saarinen, Head of Client Relations & Capital Raising and Partner. We hope you and your families are all well in these turbulent times of the COVID-19 pandemic. The spreading is now...